Posted in | News | Diamond

Global Witness Exits Kimberely Process Citing Concerns Over Zimbabwe

Global Witness has decided to depart from the Kimberely Process. The human rights watchdog made the decision on Monday and cited an outdated approach by the program to certify diamond exports as the reason for this decision.

The watchdog said that they objected in particular to the decision made by the Kimberly Process regarding the diamond sales approval of the Marange field diamonds from Zimbabwe. They said that the decision made in November did not address the human rights abuses in the trade of rough diamonds.

Annie Dunnebacke, a campaigner at Global Witness said that the diamond industry has a notion that it's clean, of the Kimberly process. She added that it needed a rebrand because it was not weeding out blood diamonds.

The Founding Director Chairman of Global Witness said that the scheme had failed three tests. It failed to deal with the trade in conflict diamonds from Cote d'Ivoire, was unwilling to take serious action in the face of blatant breaches of the rules over a number of years by Venezuela and has proved unwilling to stop diamonds fueling corruption and violence in Zimbabwe.

Chairman Gooch added that despite intensive efforts over many years by a coalition of non-government organizations, the scheme’s main flaws and loopholes have not been fixed and most of the governments that run the scheme continue to show no interest in reform.

Martin Rapaport, chairman of Rapaport Group and one of the writers of the Kimberley Process on the other hand argues that the human rights were specifically excluded because governments said they wouldn't support it. Whatever the reason, Global Witness is now no longer a part of the Kimberly Process.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Global Witness Exits Kimberely Process Citing Concerns Over Zimbabwe. AZoMining. Retrieved on November 24, 2024 from https://www.azomining.com/News.aspx?newsID=5547.

  • MLA

    Scanlon, Joel. "Global Witness Exits Kimberely Process Citing Concerns Over Zimbabwe". AZoMining. 24 November 2024. <https://www.azomining.com/News.aspx?newsID=5547>.

  • Chicago

    Scanlon, Joel. "Global Witness Exits Kimberely Process Citing Concerns Over Zimbabwe". AZoMining. https://www.azomining.com/News.aspx?newsID=5547. (accessed November 24, 2024).

  • Harvard

    Scanlon, Joel. 2019. Global Witness Exits Kimberely Process Citing Concerns Over Zimbabwe. AZoMining, viewed 24 November 2024, https://www.azomining.com/News.aspx?newsID=5547.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.